- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT01141803
Effect of Apple and Apple Pomace on Inflammation and Cholesterol Metabolism in Healthy Overweight
July 19, 2016 updated by: Arne Astrup, University of Copenhagen
Isafruit: Nutrigenomics in Overweight
The investigators will assess the protective and antiinflammatory effects of processed fruit and fruit fibre in overweight subjects with signs of metabolic syndrome.
A single-blinded parallel study is conducted to investigate the protective effects of fruit fibre on colonic epithelium.
Relevant signalling pathways related to cholesterol metabolism, vascular inflammation, oxidative defence, apoptosis and sterol metabolism will be targeted.
Volunteers are randomly assigned one of three groups.
They are instructed to follow a polyphenol and pectin restricted diet for six weeks.
The last four weeks in this six week period, the restricted diet is supplemented with whole apples (550g/day), apple pomace (22g/day) or nothing.
Blood, urine, faecal samples and colon biopsies are collected before and after the four weeks intervention period.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Study Type
Interventional
Enrollment (Actual)
37
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
-
Frederiksberg, Denmark, 1951
- Department of Human Nutrition, Life, University of Copenhagen
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years and older (Adult, Older Adult)
Accepts Healthy Volunteers
Yes
Genders Eligible for Study
All
Description
Inclusion Criteria:
- Healthy
- BMI over 30
- No daily medication
- Not strenuous exercise > 10hours/week
- No blood donation 3 months before or during the study
Exclusion Criteria:
- Smoking
- Simultaneous participation in other research projects
- Use of any dietary supplements
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Prevention
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
No Intervention: control
|
|
Active Comparator: Apples
|
550g of apples/day
|
Active Comparator: Apple pomace
|
22g apple pomace/day
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Time Frame |
---|---|
Blood lipid profile (triacylglycerol and total-, LDL- and HDL-cholesterol)
Time Frame: Measured at week 2
|
Measured at week 2
|
Blood lipid profile (triacylglycerol and total-, LDL- and HDL-cholesterol)
Time Frame: Measured at week 6
|
Measured at week 6
|
Secondary Outcome Measures
Outcome Measure |
Time Frame |
---|---|
Blood pressure
Time Frame: Measured at week 2
|
Measured at week 2
|
Blood pressure
Time Frame: Measured at week 6
|
Measured at week 6
|
Anthropometry (weight, height, waist and hip circumference)
Time Frame: Measured at week 2
|
Measured at week 2
|
Anthropometry (weight, height, waist and hip circumference)
Time Frame: Measured at week 6
|
Measured at week 6
|
Inflammatory marker (hs-CRP)
Time Frame: Measured at week 2
|
Measured at week 2
|
Inflammatory marker (hs-CRP)
Time Frame: Measured at week 6
|
Measured at week 6
|
Faeces analyses (metabolomics, pH, bile acids, short-chain fatty acids)
Time Frame: Measured at week 2
|
Measured at week 2
|
Faeces analyses (metabolomics, pH, bile acids, short-chain fatty acids)
Time Frame: Measured at week 6
|
Measured at week 6
|
Urine analyses (metabolomics)
Time Frame: Measured at week 2
|
Measured at week 2
|
Urine analyses (metabolomics)
Time Frame: Measured at week 6
|
Measured at week 6
|
Serum insulin, IGF-1 and IGFBP-3 levels
Time Frame: Measured at week 2
|
Measured at week 2
|
Serum insulin, IGF-1 and IGFBP-3 levels
Time Frame: Measured at week 6
|
Measured at week 6
|
Gene expression in white blood cells and colon tissue
Time Frame: Measured at week 2
|
Measured at week 2
|
Gene expression in white blood cells and colon tissue
Time Frame: Measured at week 6
|
Measured at week 6
|
Enzyme activity in lysed erythrocytes (glutathione peroxidase)
Time Frame: Measured at week 2
|
Measured at week 2
|
Enzyme activity in lysed erythrocytes (glutathione peroxidase)
Time Frame: Measured at week 6
|
Measured at week 6
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Study Director: Susanne Bügel, PhD, Department of Human Nutrition, LIFE, University of Copenhagen, Denmark
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
July 1, 2008
Primary Completion (Actual)
December 1, 2009
Study Completion (Actual)
October 1, 2010
Study Registration Dates
First Submitted
June 8, 2010
First Submitted That Met QC Criteria
June 10, 2010
First Posted (Estimate)
June 11, 2010
Study Record Updates
Last Update Posted (Estimate)
July 20, 2016
Last Update Submitted That Met QC Criteria
July 19, 2016
Last Verified
July 1, 2016
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- M198
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
YES
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Cardiovascular Diseases
-
Medical College of WisconsinRecruitingCardiovascular Diseases | Cardiovascular Risk Factor | Cardiovascular HealthUnited States
-
Hospital Mutua de TerrassaCompleted
-
Oregon Health and Science UniversityCompletedCardiovascular Disease | Cardiovascular Risk FactorsUnited States
-
Women's College HospitalUniversity Health Network, Toronto; Sunnybrook Health Sciences Centre; Brigham... and other collaboratorsUnknownCARDIOVASCULAR DISEASESCanada, United States
-
Groupe Hospitalier Paris Saint JosephTerminatedCARDIOVASCULAR DISEASESFrance
-
University of FloridaUniversity of Alabama at Birmingham; Brown UniversityCompletedCardiovascular Disease | Psychosocial Influence on Cardiovascular DiseaseUnited States
-
VA Office of Research and DevelopmentNot yet recruitingCardiovascular DiseaseUnited States
-
Baptist Health South FloridaUniversity of California, Los Angeles; Quest Diagnostics-Nichols InsituteActive, not recruitingCardiovascular DiseaseUnited States
-
Laval UniversityActive, not recruitingCardiovascular DiseaseCanada
-
Penn State UniversityCalifornia Healthcare InstituteCompleted
Clinical Trials on Apples
-
University of GuelphAgriculture and Agri-Food Canada; Ontario Ministry of Agriculture, Food and... and other collaboratorsCompletedInflammation | Hyperlipidemias | Dysbiosis | Obesity, AbdominalCanada
-
San Diego State UniversityCompleted
-
Maastricht University Medical CenterNot yet recruitingMicrobial Colonization | Enzyme Overdose
-
Queen's University, BelfastCompletedCardiovascular DiseaseUnited Kingdom
-
University of ReadingFondazione Edmund Mach di San Michele all'AdigeCompletedMild HypercholesterolemiaUnited Kingdom
-
University of NottinghamKing's College LondonCompletedGastrointestinal SymptomsUnited Kingdom
-
Emory UniversityEunice Kennedy Shriver National Institute of Child Health and Human Development...RecruitingCerebral PalsyUnited States
-
PepsiCo Global R&DCompletedGlycemic ResponseUnited States